[HTML][HTML] Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells

M Vitiello, A Tuccoli, R D'Aurizio, S Sarti… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite increasing amounts of experimental evidence depicting the involvement of non-
coding RNAs in cancer, the study of BRAFV600E-regulated genes has thus far focused …

[HTML][HTML] miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma

MS Stark, VF Bonazzi, GM Boyle, JM Palmer… - Oncotarget, 2015 - ncbi.nlm.nih.gov
To identify 'melanoma-specific'microRNAs (miRNAs) we used an unbiased microRNA
profiling approach to comprehensively study cutaneous melanoma in relation to other solid …

MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma

L Fattore, A Sacconi, R Mancini, G Ciliberto - Cytokine & Growth Factor …, 2017 - Elsevier
Abstract microRNAs are major components of the eukaryotic post-transcriptional machinery
and are frequently deregulated during cancer development. Increasing evidence points to …

[HTML][HTML] miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2

SM Liu, J Lu, HC Lee, FH Chung, N Ma - Oncotarget, 2014 - ncbi.nlm.nih.gov
It has been well documented that miRNAs can modulate the effectiveness of cancer-
associated signaling pathways. Mitogen-activated protein kinase (MAPK/ERK) signaling …

[HTML][HTML] Oncogenic B-Raf signaling in melanoma cells controls a network of microRNAs with combinatorial functions

KL Couts, EM Anderson, MM Gross, K Sullivan… - Oncogene, 2013 - nature.com
Over two-thirds of melanomas have activating mutations in B-Raf, leading to constitutive
activation of the B-Raf/MKK/ERK signaling pathway. The most prevalent mutation, B …

MicroRNA signatures differentiate melanoma subtypes

E Chan, R Patel, S Nallur, E Ratner, A Bacchiocchi… - Cell cycle, 2011 - Taylor & Francis
Melanoma is an aggressive cancer that is highly resistance to therapies once metastasized.
We studied microRNA (miRNA) expression in clinical melanoma subtypes and evaluated …

[HTML][HTML] MicroRNA expression profiles associated with mutational status and survival in malignant melanoma

S Caramuta, S Egyházi, M Rodolfo, D Witten… - Journal of Investigative …, 2010 - Elsevier
Malignant cutaneous melanoma is a highly aggressive form of skin cancer. Despite
improvements in early melanoma diagnosis, the 5-year survival rate remains low in …

Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells

E Sakurai, C Maesawa… - International …, 2011 - spandidos-publications.com
MicroRNAs (miRNAs) are small non-coding RNAs whose aberrations are involved in the
initiation and progression of human cancers. To seek unique miRNAs contributing to …

MicroRNAs in the pathogenesis of malignant melanoma

M Glud, R Gniadecki - Journal of the European Academy of …, 2013 - Wiley Online Library
Cutaneous malignant melanoma is the most aggressive and lethal form of skin cancer. Over
the past decades, its incidence has been increasing by 3–8% per year in western countries …

[HTML][HTML] Genome-wide screen for microRNAs reveals a role for miR-203 in melanoma metastasis

W Lohcharoenkal, KD Mahapatra, L Pasquali… - Journal of Investigative …, 2018 - Elsevier
Melanoma is one of the deadliest human cancers with limited therapeutic options.
MicroRNAs are a class of short noncoding RNAs regulating gene expression at the post …